SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-071602
Filing Date
2021-05-25
Accepted
2021-05-25 09:00:41
Documents
4
Period of Report
2021-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2117300d1_8k.htm 8-K 24419
2 EXHIBIT 10.1 tm2117300d1_ex10-1.htm EX-10.1 35024
3 EXHIBIT 99.1 tm2117300d1_ex99-1.htm EX-99.1 13387
4 GRAPHIC tm2117300d1_ex10-1img01.jpg GRAPHIC 2767
  Complete submission text file 0001104659-21-071602.txt   78326
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 21958173
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences